ARRIVENT BIOPHARMA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.36 USD | +0.64% |
|
+4.01% | 0.00% |
| 08/05 | ArriVent BioPharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 30/04 | HC Wainwright Initiates ArriVent BioPharma With Buy Rating, $25 Price Target | MT |
Chart calendar ArriVent BioPharma, Inc.
16304bff182ba4.ze2lmnpn_98Hn7Cd_p9UdCde-esw-msr9hVbRFSU6mY.ia_S2E4qr_Jq3MLntshsIVc5oa12n1oGlyEaKwTisyz5tMnxDASrrFTA9Q~31b05ba4137dccea7ff7fecf42d7fa02
Upcoming events on ArriVent BioPharma, Inc.
No events available
Past events on ArriVent BioPharma, Inc.
| 08/05/2024 05:30 pm | Q1 2024 Earnings Release |
| 05/04/2024 | American Association for Cancer Research Meeting |
| 29/03/2024 01:35 am | Q4 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 -2,50 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | 0,00 -73,3 - | -80,4 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -74,6 -67,6 -10.39% | -102 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -69,3 -61,3 -13.18% | -80,6 |
|
Net income Million USD | Released Forecast Spread | -36,9 | -69,3 -61,3 -13.18% | -80,6 |
|
EPS USD | Released Forecast Spread | -1,90 | -32,4 -11,3 -186.39% | -3,52 |
| Announcement Date | 25/08/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | |
|
EBITDA Million USD | Released Forecast Spread | -20,7 -19,2 -7.64% | -19,8 | -20,4 | -21,0 | |||
|
EBIT Million USD | Released Forecast Spread | -24,3 | -20,7 -29,2 29.18% | -22,8 | -25,4 | -24,6 | -28,0 | -28,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -17,4 -19,4 10.35% | -19,5 | -20,5 | -21,0 | -25,0 | -26,1 | |
|
Net income Million USD | Released Forecast Spread | -17,4 -19,4 10.35% | -19,5 | -20,5 | -21,0 | -25,0 | -26,1 | |
|
EPS USD | Released Forecast Spread | -0,70 -0,94 25.23% | -0,58 | -0,61 | -0,62 | -0,73 | -0,76 | |
| Announcement Date | - | 08/05/24 | - | - | - | - | - |
More events
Past sector events for ArriVent BioPharma, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- AVBP Stock
- Calendar ArriVent BioPharma, Inc.